Isaac Ben-Bassat

Medicine & Life Sciences

1. Leukemia 100%
2. Precursor Cell Lymphoblastic Leukemia-Lymphoma 83%
3. B-Cell Chronic Lymphocytic Leukemia 74%
4. Hodgkin Disease 71%
5. Non-Hodgkin's Lymphoma 57%
6. Acute Myeloid Leukemia 55%
7. Stem Cell Transplantation 52%
8. Burkitt Lymphoma 50%
9. Drug Therapy 49%
10. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 49%
11. Lymphoma 42%
12. Lymphocytes 41%
13. Hematopoietic Stem Cell Transplantation 39%
14. Therapeutics 39%
15. Bone Marrow 35%
16. Hematologic Neoplasms 34%
17. Meta-Analysis 33%
18. Israel 31%
19. Multiple Myeloma 30%
20. T-Lymphocytes 30%
21. Clonal Evolution 29%
22. Plasmacytoma 28%
23. Interferons 28%
24. Systematic Reviews 28%
25. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 27%
26. Immunoglobulins 26%
27. Vincristine 26%
28. Imatinib Mesylate 26%
29. Neoplasms 25%
30. Acute Promyelocytic Leukemia 25%
31. Haemolytic Anaemia 25%
32. Immunoglobulin Heavy Chains 24%
33. Rituximab 24%
34. Aplastic Anaemia 24%
35. 5'-Nucleotidase 24%
36. Bone Marrow Transplantation 23%
37. Survival 23%
38. Genes 23%
39. Cytarabine 22%
40. Recurrence 22%
41. Immunoglobulin Genes 20%
42. Intravenous Immunoglobulins 20%
43. ibritumomab tiuxetan 20%
44. Congenital Hemolytic Anemia 19%
45. Fluorescence In Situ Hybridization 19%
46. Globins 19%
47. Adenosine Deaminase 18%
48. Allogeneic Cells 18%
49. Child 18%
50. Thalidomide 18%